logo

For the Inventor, By the Inventor

Gaithersburg, MD, United States of America

Altimmune, Inc.


USPTO Granted Patents = 12

% Expired Patents = 41.7


Forward Citations = 18

Loading Chart...
Loading Chart...

13 inventors (with patents filed for the assignee):

goldMedal De-Chu C Tang (6 out of 11 patents)

silverMedal Kent R Van Kampen (3 out of 7 patents)

bronzeMedal De-chu C Tang (3 out of 3 patents)

4.  M Scot Roberts (2 out of 2 patents)

5.  Haroldo E Toro (2 out of 5 patents)

6.  Aime K Johnson (1 out of 1 patent)

7.  Prachi Sangle (1 out of 1 patent)

8.  Allan E David (1 out of 2 patents)

9.  Henry J Baker (1 out of 8 patents)

10.  Bertrand Victor Gilbert Georges (1 out of 8 patents)

11.  John J Nestor (1 out of 14 patents)

12.  Chun-Ming Huang (1 out of 2 patents)

13.  JianFeng Zhang (1 out of 1 patent)

14.  Harold Toro (0 patent)


12 patents:

1. 11541028 - Peptide pharmaceuticals for treatment of NASH and other disorders (2023-01-03),
2. 11395802 - Biodegradable polymeric particles encapsulating an active agent, pharmaceutical compositions and uses thereof (2022-07-26),
3. 11382968 - Coronavirus immunogenic compositions and uses thereof (2022-07-12),
4. 11141477 - Rapid and prolonged immunologic-therapeutic (2021-10-12),
5. 11040100 - Rapid and prolonged immunogic therapeutic (2021-06-22),
6. 11040099 - Rapid and prolonged immunologic therapeutic (2021-06-22),
7. 10744195 - Immunization of avians by administration of non-replicating vectored vaccines (2020-08-18),
8. 10183069 - Rapid and prolonged immunologic-therapeutic (2019-01-22),
9. 9968667 - Targets and compositions for use in decontamination, immunoprophylaxis, and post-exposure therapy against anthrax (2018-05-15),
10. 9855328 - Immunization of avians by administration of non-replicating vectored vaccines (2018-01-02),
11. 9605275 - Rapid and prolonged immunologic-therapeutic (2017-03-28),
12. 9175310 - Rapid and prolonged immunologic-therapeutic (2015-11-03),
Company Overview
Altimmune, Inc. is a biopharmaceutical company based in Gaithersburg, Maryland, focused on developing innovative therapeutics for the treatment of infectious diseases and immune-related conditions. The company specializes in the discovery and advancement of novel immunotherapies and vaccines, leveraging its proprietary technology platforms to create solutions that enhance immune responses. Altimmune's research encompasses a range of therapeutic areas, aiming to address significant unmet medical needs through cutting-edge science and development.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

Altimmune, Inc. USPTO Patent Assignee Logo
12 Patents

#40 in Gaithersburg, MD

#353 in Maryland

#25,540 in US

#48,129 in the World

Gaithersburg, MD (US)
Gaithersburg, MD, United States of America

Altimmune, Inc.

Forward Citations = 18

13 inventors:

goldMedal De-Chu C Tang (6 out of 11 patents)

silverMedal Kent R Van Kampen (3 out of 7 patents)

bronzeMedal De-chu C Tang (3 out of 3 patents)

4.  M Scot Roberts (2 out of 2 patents)

5.  Haroldo E Toro (2 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Altimmune, Inc.. Retrieved from https://idiyas.com/company/altimmune

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…